5-bromo-4-[4-[5-[4-fluoro-3-(trifluoromethyl)phenyl]-1-methylimidazol-2-yl]piperidin-1-yl]pyrimidine
C20H18BrF4N5 — CID 141442764
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-bromo-4-[4-[5-[4-fluoro-3-(trifluoromethyl)phenyl]-1-methylimidazol-2-yl]piperidin-1-yl]pyrimidine
5-bromo-4-[4-[5-[4-fluoro-3-(trifluoromethyl)phenyl]-1-methylimidazol-2-yl]piperidin-1-yl]pyrimidine (PubChem CID 141442764) has the molecular formula C20H18BrF4N5 and a molecular weight of 484.30 g/mol. Its IUPAC name is 5-bromo-4-[4-[5-[4-fluoro-3-(trifluoromethyl)phenyl]-1-methylimidazol-2-yl]piperidin-1-yl]pyrimidine.
Molecular Properties
| Compound Name | 5-bromo-4-[4-[5-[4-fluoro-3-(trifluoromethyl)phenyl]-1-methylimidazol-2-yl]piperidin-1-yl]pyrimidine |
|---|---|
| PubChem CID | 141442764 |
| Molecular Formula | C20H18BrF4N5 |
| Molecular Weight | 484.30 g/mol |
| Exact Mass | 483.07 |
| IUPAC Name | 5-bromo-4-[4-[5-[4-fluoro-3-(trifluoromethyl)phenyl]-1-methylimidazol-2-yl]piperidin-1-yl]pyrimidine |
| SMILES | Cn1c(-c2ccc(F)c(C(F)(F)F)c2)cnc1C1CCN(c2ncncc2Br)CC1 |
| InChI | InChI=1S/C20H18BrF4N5/c1-29-17(13-2-3-16(22)14(8-13)20(23,24)25)10-27-18(29)12-4-6-30(7-5-12)19-15(21)9-26-11-28-19/h2-3,8-12H,4-7H2,1H3 |
| InChIKey | GIAYIYJCFGMTSJ-UHFFFAOYSA-N |
| XLogP | 5.18 |
| TPSA | 46.84 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 484.30 |
| LogP ≤ 5 | 5.18 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 141442764 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.